Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Condition(s):Mycosis Fungoides; Lymphomatoid Papulosis; Sezary SyndromeLast Updated:December 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Mycosis Fungoides; Lymphomatoid Papulosis; Sezary SyndromeLast Updated:December 13, 2023Recruiting
Condition(s):LymphomaLast Updated:May 30, 2012Completed
Condition(s):Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides/Sezary SyndromeLast Updated:February 22, 2024Terminated
Condition(s):Non-Hodgkin Lymphoma (NHL); Cutaneous Lymphoma; Cutaneous T-cell Lymphoma (CTCL); Mycosis Fungoides; Sezary SyndromeLast Updated:April 5, 2017Completed
Condition(s):LymphomaLast Updated:December 1, 2020Completed
Condition(s):Mycosis Fungoides and Sézary SyndromeLast Updated:February 13, 2023Recruiting
Condition(s):Cutaneous T Cell Lymphoma; Mycosis Fungoides/Sezary SyndromeLast Updated:December 6, 2023Active, not recruiting
Condition(s):Emotions; CorticosteroidsLast Updated:March 20, 2024Recruiting
Condition(s):LymphomaLast Updated:December 18, 2013Unknown status
Condition(s):Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides/Sezary SyndromeLast Updated:July 14, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.